SHIP inhibition mediates select TREM2-induced microglial functions

• Published in: Molecular immunology 2024-06, Vol.170, p.35-45
• Main Authors: Ramakrishnan, Gautham S., Berry, William L., Pacherille, Angela, Kerr, William G., Chisholm, John D., Pedicone, Chiara, Humphrey, Mary Beth
• Format: Article
• Language: English
• Subjects: Alzheimer Disease - genetics; Alzheimer Disease - metabolism; Alzheimer’s disease; Amyloid beta-Peptides - metabolism; Animals; Apoptosis - genetics; Cell Line; Humans; Lysosomes - metabolism; Membrane Glycoproteins - genetics; Membrane Glycoproteins - metabolism; Mice; Microglia; Microglia - metabolism; Mitochondria - metabolism; Phagocytosis; Phagocytosis - genetics; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases - genetics; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases - metabolism; Receptors, Immunologic - genetics; Receptors, Immunologic - metabolism; SHIP inhibitors; SHIP1; Signal Transduction; TREM2
• ISSN: 0161-5890; 1872-9142; 1872-9142
• DOI: 10.1016/j.molimm.2024.04.002

Microglia play a pivotal role in the pathology of Alzheimer's Disease (AD), with the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) central to their neuroprotective functions. The R47H variant of TREM2 has emerged as a significant genetic risk factor for AD, leading to a loss-of-function phenotype in mouse AD models. This study elucidates the roles of TREM2 in human microglia-like HMC3 cells and the regulation of these functions by SH2-containing inositol-5′-phosphatase 1 (SHIP1). Using stable cell lines expressing wild-type TREM2, the R47H variant, and TREM2-deficient lines, we found that functional TREM2 is essential for the phagocytosis of Aβ, lysosomal capacity, and mitochondrial activity. Notably, the R47H variant displayed increased phagocytic activity towards apoptotic neurons. Introducing SHIP1, known to modulate TREM2 signaling in other cells, revealed its role as a negative regulator of these TREM2-mediated functions. Moreover, pharmacological inhibition of both SHIP1 and its isoform SHIP2 amplified Aβ phagocytosis and lysosomal capacity, independently of TREM2 or SHIP1 expression, suggesting a potential regulatory role for SHIP2 in these functions. The absence of TREM2, combined with the presence of both SHIP isoforms, suppressed mitochondrial activity. However, pan-SHIP1/2 inhibition enhanced mitochondrial function in these cells. In summary, our findings offer a deeper understanding of the relationship between TREM2 variants and SHIP1 in microglial functions, and emphasize the therapeutic potential of targeting the TREM2 and SHIP1 pathways in microglia for neurodegenerative diseases. •TREM2 plays a critical role in the neuroprotective functions of microglia in Alzheimer’s disease (AD).•In this study, we have demonstrated the regulatory role of SHIP1 in TREM2-mediated functions in microglia.•Pan SHIP-1/2 inhibitors can improve select microglial functions independently of TREM2 and SHIP1